Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    Kava | NCCAM
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Terminated Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
Condition: Anxiety Disorders
Interventions: Drug: Venlafaxine ER;   Drug: Sugar pill;   Drug: Kava

Indicates status has not been verified in more than two years